Canaccord Genuity initiates LB Pharmaceuticals with Buy, $65 target
Canaccord Genuity started coverage of LB Pharmaceuticals (LBRX) with a Buy rating and a $65 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.